학술논문
Emerging preclinical modulators developed for F508del-CFTR have the potential to be effective for ORKAMBI resistant processing mutants
Document Type
Article
Author
Source
In Journal of Cystic Fibrosis January 2021 20(1):106-119
Subject
Language
ISSN
1569-1993